Dihydrogen bisoxalatoplatinate(II)
|
812-279-3
|
83771-84-0
|
Met. Corr. 1
Acute Tox. 4
Acute Tox. 4
Skin Corr. 1C
Eye Dam. 1
Acute Tox. 4
|
Notified C&L
|
View details
|
[(r)-(-)-1-[(s)-2-(diphenylphosphino)-ferrocenyl]-ethyldi-tert.butylphosphine-(1,5-cyclooctadiene)-rhodium(I)]-tetrafluoroborate
|
812-280-9
|
673458-86-1
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Dam. 1
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Dirhodium(II) tetrakisacetate hydrate
|
812-281-4
|
29998-99-0
|
Flam. Sol. 1
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Rhodium oxide (Rh2O3), pentahydrate
|
812-283-5
|
39373-27-8
|
|
Notified C&L
|
View details
|
Chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]-{[1,3-bis[2,6-bis(diphenylmethyl)-4-methylphenyl]-2H-imidazol-2-ylidene}palladium(II), min. 97%
|
812-284-0
|
1380314-24-8
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
chloro[(S)-2,2´-bis(bis(3,5-dimethylphenyl)phosphino)-1,1´-binaphthyl](p-cymene)ruthenium(II) chloride
|
812-285-6
|
1345887-44-6
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
[N-[(1R,2R)-2-(amino-κN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-κN]chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl]-rhodium Stereoisomer
|
812-286-1
|
223392-99-2
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
Aquatic Chronic 4
|
Notified C&L
|
View details
|
Reaction mass of bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] adipate and [2-[2-(2-butoxyethoxy)ethoxy]ethyl] 3,6,9,12-tetraoxahexadec-1-yl adipate
|
943-330-9
|
|
|
REACH registration C&L
|
View details
|
(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
|
812-287-7
|
1192651-49-2
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt
|
812-288-2
|
115970-66-6
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium tetrafluoroborate
|
812-289-8
|
172491-72-4
|
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium perchlorate
|
812-290-3
|
173894-27-4
|
|
Notified C&L
|
View details
|
H-Cys(1)-Cys(2)-Glu-Tyr-Cys(3)-Cys(1)-Asn-Pro-Ala-Cys(2)-Thr-Gly-Cys(3)-Tyr-OH
|
812-291-9
|
851199-59-2
|
|
Notified C&L
|
View details
|
1-Bromo-2-phenoxy-benzene
|
812-295-0
|
7025-06-1
|
Acute Tox. 4
Acute Tox. 4
Acute Tox. 4
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,3,3-trimethyl-3H-indolium 4-methylbenzenesulfonate
|
812-296-6
|
205744-92-9
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-(3-ethyl-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3-ethyl-1,1-dimethyl-1H-benzo[e]indolium tetrafluoroborate
|
812-297-1
|
193687-63-7
|
|
Notified C&L
|
View details
|
reaction mass of 1,1,1,2,2,3,3,4,4,5,5,6,6,6-tetradecafluoro-hexane and 1,1,1,2,2,3,3,4,5,5,5-undecafluoro-4-(trifluoromethyl)pentane
|
943-336-1
|
|
|
Notified C&L
|
View details
|
Pyridinium, 4-formyl-1-methyl-
|
812-298-7
|
13441-53-7
|
|
Notified C&L
|
View details
|
(1-Cyanomethyl-cyclopropyl)-acetonitrile
|
812-299-2
|
20778-47-6
|
|
Notified C&L
|
View details
|
4-Fluorobenzofuran
|
812-300-6
|
24410-58-0
|
|
Notified C&L
|
View details
|
Sodium ethanesulfinate
|
812-301-1
|
20035-08-9
|
|
Notified C&L
|
View details
|
(R)-Pyrrolidine-3-carboxamide hydrochloride
|
812-302-7
|
1273577-42-6
|
|
Notified C&L
|
View details
|
3-Bromo-2-methylphenol
|
812-303-2
|
7766-23-6
|
|
Notified C&L
|
View details
|
Di-tert-butyl L-glutamate hydrochloride
|
812-304-8
|
32677-01-3
|
|
Notified C&L
|
View details
|
N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-methyl-L-tyrosine
|
812-305-3
|
77128-72-4
|
|
Notified C&L
|
View details
|
Fmoc-L-3-methylphenylalanine
|
812-306-9
|
211637-74-0
|
|
Notified C&L
|
View details
|
(2S)-3-(4-cyanophenyl)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid
|
812-307-4
|
173963-93-4
|
|
Notified C&L
|
View details
|
4-pyrazol-1-yl-pyridine HCl
|
943-337-7
|
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
Reaction products resulting from the esterification of C18 unsaturated fatty acid with glycerol and glycerol oligomers
|
943-350-8
|
|
|
REACH registration C&L
|
View details
|
[5-(trifluoromethyl)pyridin-2-yl]methanol
|
812-309-5
|
31181-84-7
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2A
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1-(Tetrahydropyran-2-yl)pyrazole-5-boronic acid
|
812-310-0
|
1105511-68-9
|
|
Notified C&L
|
View details
|
2-(Methoxycarbonylmethyl)phenylboronic acid pinacol ester
|
812-311-6
|
956229-86-0
|
|
Notified C&L
|
View details
|
1,7-Diaza-spiro[4.4]nonane-1-carboxylic acid tert-butyl ester
|
812-312-1
|
885268-47-3
|
|
Notified C&L
|
View details
|
1,3-Benzothiazole-2-carboxylic acid hydrate
|
812-313-7
|
3622-04-6
|
|
Notified C&L
|
View details
|
6-Chloro-N4-cyclopropylpyrimidine-2,4-diamine
|
812-314-2
|
1158781-49-7
|
|
Notified C&L
|
View details
|
3-fluoro-1H-pyrazole
|
812-315-8
|
14521-81-4
|
|
Notified C&L
|
View details
|
Reaction mass of 4-methylene-2-phenyltetrahydro-2H-pyran and 4-methyl-2-phenyl-3,6-dihydro-2H-pyran
|
943-338-2
|
|
|
REACH registration C&L
|
View details
|
1-(3-Methyl-2-pyridinyl)piperazine
|
812-316-3
|
104396-10-3
|
|
Notified C&L
|
View details
|
1-Methyl-1H-pyrazol-4-ylamine hydrochloride
|
812-317-9
|
127107-23-7
|
|
Notified C&L
|
View details
|
3-(Methylthio)-5-(trifluoromethyl)benzeneboronic acid
|
812-318-4
|
957120-83-1
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benzo[e]indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1-dimethyl-3-(4-sulfobutyl)-1H-benzo[e]indolium hydroxide, inner salt, sodium salt
|
812-320-5
|
172616-80-7
|
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(3-butyl-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene)-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium perchlorate
|
812-321-0
|
121482-73-3
|
|
Notified C&L
|
View details
|
Ethyl 2-(4-(t-BOC)piperazin-1-yl)-4-hydroxypyrimidine-5-carboxylate
|
812-322-6
|
1065074-31-8
|
|
Notified C&L
|
View details
|
1,3-Dimethyl-2,6-dioxo-5-(2-(2-(1,3,3-trimethyl-3H-indolium-2-yl)vinyl)-5-(2-(1,3,3-trimethylindolin-2-ylidene)ethylidene)cyclopent-1-en-1-yl)-1,2,3,6-tetrahydropyrimidin-4-olate
|
812-323-1
|
256520-09-9
|
|
Notified C&L
|
View details
|
3-Butyl-2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-propenyl]-1,1-dimethyl-1H-benzo[e]indolium perchlorate
|
812-324-7
|
214706-06-6
|
|
Notified C&L
|
View details
|
3-Butyl-2-[5-(3-butyl-1,3-dihydro-1,1-dimethyl-2H-benzo[e]indol-2-ylidene)-3-chloro-penta-1,3-dienyl]-1,1-dimethyl-1H-benzo[e]indolium hexafluorophosphate
|
812-325-2
|
354540-12-8
|
|
Notified C&L
|
View details
|
2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclopenten-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt
|
812-326-8
|
757960-10-4
|
|
Notified C&L
|
View details
|
2-[5-[1-(5-Carboxypentyl)-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-penta-1,3-dienyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt
|
812-327-3
|
666829-22-7
|
|
Notified C&L
|
View details
|
2-[3-(1,3-Dihydro-1,1,3-trimethyl-2H-benzo[e]indol-2-ylidene)-propenyl]-1,1,3-trimethyl-1H-benzo[e]indolium perchlorate
|
812-328-9
|
74276-27-0
|
|
Notified C&L
|
View details
|
2-(3-amino-5-methoxy-phenoxy)ethanol
|
812-329-4
|
725237-16-1
|
|
Notified C&L
|
View details
|
|
|
|
|
|
|